Document is current
Any future updates will be listed below
-
Authors
Littleton, Sheridan H. https://orcid.org/0000-0002-4322-4069
Tadross, John A. https://orcid.org/0000-0002-8424-1252
Yeo, Giles S. H. https://orcid.org/0000-0001-8823-3615
-
Funding
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/X014207/1)
Biotechnology and Biological Sciences Research Council (BB/X014207/1)
Biotechnology and Biological Sciences Research Council (BB/X014207/1)
Medical Research Council (MC_UU_00014/1)
Medical Research Council (MC_UU_00014/1)
Medical Research Council (MC_UU_00014/1)
- License Information
-
More Information
Article History
Accepted: 15 October 2025
First Online: 28 October 2025
Declarations
:
: GSHY receives grant funding from Novo Nordisk and Amgen and consults for both Novo Nordisk and Eli Lilly and Company. The other authors declare no competing interest.
